Skip to main content

Anesthesia — An Overview for the Reconstructive Urologist

The anesthetic plan is rarely the urologist's decision, but understanding it changes surgical conditions, postoperative course, and the ability to diagnose the complications that land in the PACU. This article covers the four anesthetic classes (general, regional, MAC, local), induction and maintenance principles, airway management, neuromuscular blockade and reversal, depth of anesthesia monitoring, and the anesthetic complications the urologist will encounter — malignant hyperthermia, anaphylaxis, residual neuromuscular blockade, and awareness under anesthesia.

See also: Analgesia, Nerve Blocks, Nausea & Vomiting, Positioning & Nerve Injury, ERAS.

The Four Anesthetic Classes​

ClassMechanismTypical GU use
General anesthesiaUnconscious, amnestic, analgesic, immobile; airway securedAlmost all open and MIS reconstructive work
Regional anesthesiaSensory/motor block at nerve, plexus, or spinal cord; patient awake or sedatedPerineal urethroplasty (selected), endoscopic surgery, analgesic adjunct to GA
Monitored anesthesia care (MAC)Drug-induced depression of consciousness with purposeful response to voiceCystoscopy, urodynamics, stent exchange, bladder biopsy
Local anesthesiaInfiltrative block; fully awakeMinor scrotal / vulvar procedures, in-office

The choice is driven by surgical procedure, comorbidities (particularly coagulation status for neuraxial), coagulation status, patient preference, and case duration.[1]

General Anesthesia — Induction, Maintenance, Emergence​

The Three Phases[2][3]​

  1. Induction — rapid loss of consciousness + airway secured.
  2. Maintenance — balanced anesthetic state through the operation.
  3. Emergence — reversal, extubation, return to baseline.

Common Agents and Mechanisms​

ClassExamplesMechanismClinical effect
IV hypnoticsPropofol, etomidate, thiopentalGABA-A agonismHypnosis, amnesia
Volatile anestheticsSevoflurane, desflurane, isofluraneGABA-A, glycine, K2P channelsHypnosis, immobility
KetamineKetamineNMDA antagonismDissociative anesthesia + analgesia
Nitrous oxideN₂ONMDA antagonismAdjunctive analgesia
OpioidsFentanyl, remifentanil, sufentanilμ-opioid receptorAnalgesia

Volatile vs Total Intravenous Anesthesia (TIVA)​

  • Volatile-based (sevoflurane most common) — standard for most open and MIS cases; cheap, rapid-acting, easy to titrate.
  • TIVA — propofol infusion (often with remifentanil). Preferred in malignant hyperthermia–susceptible patients, for some intraoperative neurophysiologic monitoring cases, and as part of some ERAS protocols.
  • No difference in cardiovascular events between volatile and TIVA per 2024 AHA/ACC (Class IIa, Level A).[1]
  • Modest evidence of lower postoperative nausea with TIVA and possibly lower postoperative delirium in the elderly.

Regional Anesthesia​

Neuraxial — Spinal and Epidural​

TechniqueDeliveryOnsetBest for
SpinalSingle injection into subarachnoid spaceRapid (minutes), dense blockTURP, TURBT, short perineal / pelvic procedures
EpiduralCatheter in epidural space for continuous infusionSlower, titratableOpen cystectomy, open nephrectomy, prolonged abdominal cases
Combined spinal-epidural (CSE)BothRapid + sustainedLong operations, analgesic continuation postoperatively

Benefits:[4][5]

  • Superior postoperative analgesia vs systemic opioids alone
  • Earlier return of GI function
  • Reduced pulmonary complications in high-risk and major abdominal surgery
  • Reduced systemic opioid requirement

Risks:

  • Hypotension (sympathectomy) — anticipated, treat with fluid + pressor
  • Motor weakness
  • Urinary retention
  • Postdural puncture headache — lower with atraumatic (pencil-point) needles; see Positioning & Nerve Injury
  • Epidural hematoma — rare but catastrophic; timing rules with anticoagulants are absolute (see Antithrombotic Therapy)

Peripheral Nerve Blocks​

Addressed fully in Nerve Blocks. GU-relevant options:

  • TAP block (transversus abdominis plane) — abdominal-wall analgesia for cystectomy, nephrectomy, open pelvic surgery.
  • Quadratus lumborum block — broader coverage than TAP for flank/retroperitoneal work.
  • Rectus sheath block — midline laparotomy.
  • Pudendal block — perineal urethroplasty, vaginal surgery (adjunct).
  • Ilioinguinal / iliohypogastric — inguinal/scrotal surgery.

Monitored Anesthesia Care (MAC)​

Drug-induced depression of consciousness with purposeful response to verbal commands.[6] Spontaneous ventilation is maintained. Cardiovascular function is usually preserved. Commonly uses propofol + fentanyl ± dexmedetomidine ± midazolam.

Urologic applications: flexible cystoscopy, urodynamics, stent exchange, pediatric interventional procedures, prostate biopsy in some centers.

Airway Management​

Preoperative Assessment​

Identify predictors of difficulty with:[7][8]

  • Face-mask ventilation
  • Laryngoscopy and intubation
  • Supraglottic airway placement
  • Emergency front-of-neck access

Classic predictors: Mallampati III–IV, thyromental distance, mouth opening, neck mobility, history of OSA, obesity, prior difficult intubation.

The 2022 ASA / 2025 DAS Difficult Airway Algorithm[7][9][10]​

Plan A — Tracheal intubation

  • Video laryngoscopy preferred when resources allow (2025 DAS upgrade).
  • Limit to ≤3 attempts before declaring failure.

Plan B — Supraglottic airway (SGA)

  • Second-generation SGA (with gastric access port) preferred.

Plan C — Face-mask ventilation

  • If intubation and SGA fail, maintain oxygenation by mask.

Plan D — Emergency front-of-neck airway (FONA)

  • Scalpel-bougie-tube technique for "cannot intubate, cannot oxygenate" (CICO).
  • Should be practiced — not improvised — by every anesthesiologist.

Awake Intubation​

Considered when a difficult intubation is predicted AND one of:[7][8]

  • Difficult ventilation anticipated
  • Significant aspiration risk
  • Rapid desaturation expected (obese, critically ill)

Fiberoptic or video-laryngoscope–guided under topical anesthesia + conscious sedation.

Neuromuscular Blocking Agents and Reversal​

Agents[11][12]​

TypeExamplesMechanismDuration
DepolarizingSuccinylcholineACh-receptor agonist (depolarizes)Ultra-short (5–10 min); RSI
Non-depolarizing (intermediate)Rocuronium, vecuroniumCompetitive antagonist~30–60 min
Non-depolarizing (long)PancuroniumCompetitive antagonistLargely historical
BenzylisoquinoliniumCisatracuriumHofmann eliminationIntermediate; useful in renal/hepatic failure

Succinylcholine is the classical RSI agent; contraindications include MH susceptibility, recent burn or spinal cord injury (hyperkalemia risk), and myopathies.

Monitoring Blockade​

  • Train-of-four (TOF) — 4 stimuli at 2 Hz; ratio of 4th to 1st twitch amplitude.
  • TOF ratio ≥0.9 required before extubation to avoid residual blockade.[11]
  • 2023 ASA guideline: quantitative TOF monitoring at the adductor pollicis is recommended.

Reversal​

AgentReversesEffective atNotes
SugammadexRocuronium, vecuroniumDeep, moderate, or shallow blockadeSelective relaxant-binding agent; rapid and reliable; FDA-approved
Neostigmine (+ glycopyrrolate or atropine)Any non-depolarizing NMBAOnly minimal blockade (TOF 0.4–0.9)AChE inhibitor; cannot reverse deep blockade

Residual Blockade Consequences​

Residual NMB (TOF <0.9 at extubation) is associated with:[11]

  • Upper airway obstruction
  • Reintubation
  • Atelectasis and pneumonia
  • Prolonged PACU stay

Deep Blockade for Laparoscopic Surgery​

A Cochrane review found deep NMB during abdominal laparoscopy modestly improves surgical conditions (view, working space, lower insufflation pressures).[12] In robotic pelvic urology, deep blockade is often requested by the primary surgeon.

Depth of Anesthesia Monitoring​

Bispectral Index (BIS)​

EEG-derived 0–100 scale:[17][18]

  • Maintenance target: 40–60
  • 15 min before end of case: 55–70 (to speed emergence)

Benefits[17][18]​

  • Reduced postoperative delirium (particularly elderly)
  • Higher intraoperative MAP (less overshooting anesthetic depth)
  • Reduced anesthetic consumption
  • Mixed but probably modest reduction in intraoperative awareness

Intraoperative Awareness​

Rare but distressing — ~0.1–0.2% of general anesthetics. Higher-risk contexts include cardiac surgery, trauma, cesarean section, and patients with limited hemodynamic reserve requiring "light" anesthesia.[17]

Anesthetic Complications​

Malignant Hyperthermia (MH)​

Definition: pharmacogenetic hypermetabolic crisis triggered by volatile anesthetics or succinylcholine in susceptible individuals.[13][14][15]

Triggers:

  • Volatile anesthetics — sevoflurane, desflurane, isoflurane, halothane
  • Succinylcholine

Incidence: 1:10,000 to 1:250,000 anesthetics; genetic prevalence up to 1:400 (ryanodine receptor / RYR1 mutation).

Clinical signs — in order of appearance:

  • Unexplained rise in end-tidal CO₂ (earliest, most sensitive)
  • Tachycardia, hypertension
  • Muscle rigidity — masseter spasm is highly specific
  • Hyperthermia (often a late finding)
  • Hyperkalemia → arrhythmia
  • Rhabdomyolysis, cola-colored urine
  • Metabolic acidosis
  • DIC (late)

Treatment:

  1. Stop all triggering agents immediately.
  2. Call for help; activate MH protocol.
  3. Dantrolene — 2.5 mg/kg IV bolus, repeat as needed (max 10 mg/kg) — the specific antagonist.
  4. Hyperventilate with 100% O₂ to blow off CO₂.
  5. Active cooling — cold saline, cooling blanket, ice packs to groin/axilla, cold bladder/nasogastric lavage.
  6. Treat hyperkalemia (calcium, insulin/glucose, bicarb).
  7. Treat arrhythmias (amiodarone for VT; avoid calcium channel blockers with dantrolene).
  8. Monitor for DIC, rhabdomyolysis (alkalinize urine, maintain diuresis), renal failure.

Mortality: has fallen from >80% historically to <5% with dantrolene + protocol.[14][15]

MH-susceptible patient management: TIVA with propofol + non-triggering agents; vapor-free anesthesia machine preparation.

Anaphylaxis​

Most concerning anesthesia-related drug reaction.[16]

Common culprits: NMBAs (most commonly rocuronium, succinylcholine), antibiotics (cefazolin, vancomycin), latex, chlorhexidine, sugammadex (rare).

Presentation under GA — may be delayed and atypical (hypotension, bronchospasm, rising airway pressures, desaturation, loss of ETCO₂ trace). Rash may be masked by drapes.

Treatment: epinephrine (first line), IV fluids, airway/ventilation support, secondary lines (antihistamine, steroid).

Residual Neuromuscular Blockade​

Covered above — TOF ratio ≥0.9 before extubation; sugammadex for rocuronium/vecuronium reversal.

Postoperative Nausea and Vomiting (PONV)​

Covered in Nausea & Vomiting.

Hypothermia​

Maintain core temperature >36°C with forced-air warming, warmed IV fluids and insufflation gas. Hypothermia increases SSI, coagulopathy, and cardiac events.

Regional vs General — Outcomes​

SettingFindingReference
Cardiovascular events, volatile vs TIVANo difference (IIa, Level A)[1]
Cardiovascular events, neuraxial vs GANo difference when neuraxial feasible (IIa, Level B-R)[1]
Postoperative delirium, regional vs GA (hip fracture — RAGA trial)No significant difference[19]
Postoperative mortality / major morbidity (Cochrane overview)Neuraxial may reduce in high-risk / major surgery[4]

The practical takeaway: choose regional vs GA for procedure-specific advantages (analgesic continuation, avoiding airway instrumentation, anticoagulation timing) rather than expecting a major cardiovascular-outcome difference.

Multimodal Postoperative Analgesia — Principles​

Full coverage in Analgesia. Core multimodal components:[5][20][21][22]

  1. Scheduled acetaminophen — first-line baseline
  2. NSAID / COX-2 inhibitor — opioid-sparing (NSAID caveat with bowel anastomosis — see Bowel Anastomosis)
  3. Regional anesthesia — procedure-specific block
  4. Dexamethasone — anti-inflammatory + antiemetic (single perioperative dose)
  5. Gabapentinoids — evidence mixed; use selectively; watch sedation/falls
  6. IV ketamine or lidocaine infusions — major abdominal surgery
  7. Opioids — rescue, not baseline

Neuraxial analgesia is strongly recommended for major thoracic and abdominal surgery (strong recommendation, high-quality evidence).[5] The NO PAin trial confirmed that opioid-sparing acetaminophen + NSAID pathways reduce postoperative opioid consumption without worsening pain scores or satisfaction.[23]

The Surgeon's Intraoperative Communication Checklist​

A useful short list for the reconstructive urologist:

  • Before incision: share anticipated blood loss, positioning plan, expected duration, key hemodynamic moments (renal hilar control, urethral anastomosis, bowel resection/anastomosis), and planned regional block / local infiltration.
  • During surgery: request deeper blockade if exposure requires it; request pressor or hemodynamic adjustment during critical steps; coordinate hypotensive episodes with high-bleed-risk steps.
  • Near end of case: agree on extubation plan (deep vs awake), analgesic transition, antiemetic plan, and PACU disposition (floor vs step-down vs ICU).

Key Takeaways for the Reconstructive Urologist​

TopicKey point
Anesthetic classesGeneral (volatile or TIVA), regional (neuraxial or peripheral), MAC, local
Cardiovascular outcomesNo difference between volatile/TIVA or neuraxial/GA
AirwayVideo laryngoscopy preferred, ≤3 attempts, know CICO algorithm
NMBATOF ≥0.9 before extubation; sugammadex for roc/vec reversal
Malignant hyperthermiaRising ETCO₂ earliest; dantrolene 2.5 mg/kg specific treatment; mortality <5% with protocol
Depth monitoringBIS 40–60; reduces delirium in elderly
Multimodal analgesiaAcetaminophen + NSAID + regional; opioid as rescue only
Regional anesthesiaNeuraxial strongly recommended for major abdominal / thoracic

References​

1. Thompson A, Fleischmann KE, Smilowitz NR, et al. "2024 AHA/ACC Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery." J Am Coll Cardiol. 2024;84(19):1869–1969. doi:10.1016/j.jacc.2024.06.013

2. Miller D, Lewis SR, Pritchard MW, et al. "Intravenous Versus Inhalational Maintenance of Anaesthesia for Postoperative Cognitive Outcomes in Elderly People Undergoing Non-Cardiac Surgery." Cochrane Database Syst Rev. 2018;8:CD012317. doi:10.1002/14651858.CD012317.pub2

3. Brown EN, Lydic R, Schiff ND. "General Anesthesia, Sleep, and Coma." N Engl J Med. 2010;363(27):2638–50. doi:10.1056/NEJMra0808281

4. Guay J, Choi P, Suresh S, et al. "Neuraxial Blockade for the Prevention of Postoperative Mortality and Major Morbidity — An Overview of Cochrane Systematic Reviews." Cochrane Database Syst Rev. 2014;(1):CD010108. doi:10.1002/14651858.CD010108.pub2

5. Chou R, Gordon DB, de Leon-Casasola OA, et al. "Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, ASRA, and ASA Committee on Regional Anesthesia." J Pain. 2016;17(2):131–57. doi:10.1016/j.jpain.2015.12.008

6. American Society of Anesthesiologists Task Force. "Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018." Anesthesiology. 2018;128(3):437–479. doi:10.1097/ALN.0000000000002043

7. Rosenblatt WH, Yanez ND. "A Decision Tree Approach to Airway Management Pathways in the 2022 Difficult Airway Algorithm of the American Society of Anesthesiologists." Anesth Analg. 2022;134(5):910–915. doi:10.1213/ANE.0000000000005930

8. Law JA, Duggan LV, Asselin M, et al. "Canadian Airway Focus Group Updated Consensus-Based Recommendations for Management of the Difficult Airway." Can J Anaesth. 2021;68(9):1405–1436. doi:10.1007/s12630-021-02008-z

9. Frerk C, Mitchell VS, McNarry AF, et al. "Difficult Airway Society 2015 Guidelines for Management of Unanticipated Difficult Intubation in Adults." Br J Anaesth. 2015;115(6):827–48. doi:10.1093/bja/aev371

10. Ahmad I, El-Boghdadly K, Iliff H, et al. "Difficult Airway Society 2025 Guidelines for Management of Unanticipated Difficult Tracheal Intubation in Adults." Br J Anaesth. 2025. doi:10.1016/j.bja.2025.10.006

11. Thilen SR, Weigel WA, Todd MM, et al. "2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade." Anesthesiology. 2023;138(1):13–41. doi:10.1097/ALN.0000000000004379

12. Bijkerk V, Jacobs LM, Albers KI, et al. "Deep Neuromuscular Blockade in Adults Undergoing an Abdominal Laparoscopic Procedure." Cochrane Database Syst Rev. 2024;1:CD013197. doi:10.1002/14651858.CD013197.pub2

13. Litman RS, Rosenberg H. "Malignant Hyperthermia: Update on Susceptibility Testing." JAMA. 2005;293(23):2918–24. doi:10.1001/jama.293.23.2918

14. Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. "Malignant Hyperthermia: A Review." Orphanet J Rare Dis. 2015;10:93. doi:10.1186/s13023-015-0310-1

15. Rosenberg H, Davis M, James D, Pollock N, Stowell K. "Malignant Hyperthermia." Orphanet J Rare Dis. 2007;2:21. doi:10.1186/1750-1172-2-21

16. Patton K, Borshoff DC. "Adverse Drug Reactions." Anaesthesia. 2018;73(Suppl 1):76–84. doi:10.1111/anae.14143

17. Lewis SR, Pritchard MW, Fawcett LJ, Punjasawadwong Y. "Bispectral Index for Improving Intraoperative Awareness and Early Postoperative Recovery in Adults." Cochrane Database Syst Rev. 2019;9:CD003843. doi:10.1002/14651858.CD003843.pub4

18. Ceresoli M, Braga M, Zanini N, et al. "Enhanced Perioperative Care in Emergency General Surgery — WSES Position Paper." World J Emerg Surg. 2023;18(1):47. doi:10.1186/s13017-023-00519-2

19. Li T, Li J, Yuan L, et al. "Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial." JAMA. 2022;327(1):50–58. doi:10.1001/jama.2021.22647

20. Coccolini F, Corradi F, Sartelli M, et al. "Postoperative Pain Management in Non-Traumatic Emergency General Surgery — WSES-GAIS-SIAARTI-AAST Guidelines." World J Emerg Surg. 2022;17(1):50. doi:10.1186/s13017-022-00455-7

21. Joshi GP. "Rational Multimodal Analgesia for Perioperative Pain Management." Curr Pain Headache Rep. 2023;27(8):227–237. doi:10.1007/s11916-023-01137-y

22. Raeder J. "Pain Treatment and Prophylaxis on Pain." Curr Opin Anaesthesiol. 2022;35(6):684–690. doi:10.1097/ACO.0000000000001190

23. NO PAin Investigators, Gazendam A, Ekhtiari S, et al. "Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy." JAMA. 2022;328(13):1326–1335. doi:10.1001/jama.2022.16844